Stuart A. Arbuckle - 21 Jun 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Hunter Smith, attorney-in-fact for Stuart A. Arbuckle
Issuer symbol
RYTM
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:30:38 UTC
Previous filing
20 Jun 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (right to buy) Award $0 +14,000 $0.000000 14,000 21 Jun 2023 Common Stock 14,000 $18.47 Direct F1
transaction RYTM Restricted Stock Units Award $0 +3,000 $0.000000 3,000 21 Jun 2023 Common Stock 3,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F3 The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.